Chinese pharmaceutical company Sinopharm will start the third phase of a COVID-19 vaccine clinical trial in Peru. Around 12,000 vaccines already arrived in Lima. Phase three of the trial will include 6,000 people between the ages of 18 and 75. Trials with thousands of participants allow researchers to gather data on the efficacy of vaccines to pass regulatory approvals.
Subscribe to us on YouTube: [ Ссылка ]
Download our APP on Apple Store (iOS): [ Ссылка ]
Download our APP on Google Play (Android): [ Ссылка ]
Follow us on:
Website: [ Ссылка ]
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Pinterest: [ Ссылка ]
Weibo: [ Ссылка ]
Douyin: [ Ссылка ]
